Skip to main content
. 2021 Jan 8;11:600684. doi: 10.3389/fimmu.2020.600684

Figure 3.

Figure 3

Potential implications of documented leukocyte modulation in ECMO patient outcomes. human leukocyte antigen (HLA)-DR, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-10, acute kidney injury (AKI), toll-like receptor (TLR)-4, lipopolysaccharides (LPS), von Willebrand factor (vWF) (Figure partially created with BioRender.com).